Abstract
Prostanoids are unsaturated cyclic fatty acids, are synthesized primarily from arachidonic acid, and, like the leukotrienes, belong to the growing family of eicosanoids. As tissue hormones, prostanoids act on specific receptors near their site of synthesis and degradation. Prostanoids operate as modulators and mediators in a large spectrum of physiological processes. They are involved in the regulation of maternal and fetal circulation, patency of the ductus arteriosus, plateletvessel wall interaction and kidney function. Besides their physiological function in protecting organ perfusion under stress conditions, they are also involved in diseases as described in the hyperprostaglandin E2-syndrome or — together with leukotrienes-in inflammatory processes. More specific pharmacological tools than the nonsteroidal antiinflammatory drugs, such as receptor antagonists, selective synthesis inhibitors, and eicosanoid analogues offer the prospect of enriching our arsenal of pharmacotherapeutic interventions in a variety of diseases. Before active intervention, however, more and specific biochemical analyses are required to identify the pathophysiological role of eicosanoid.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
Abbreviations
- PG:
-
prostaglandin
- Tx:
-
thromboxane
- PGE-M:
-
7α-hydroxy-5,11-diketotetranorprostane-1,16-dioic acid
- SRS-A:
-
slow reacting substance of anaphylaxis
- NSAI drugs:
-
nonsteroidal anti-inflammatory drugs
- PDA:
-
patent ductus arteriosus
References
Adelroth E, Morris MM, Harcreave FE, O'Byrne PM (1986) Airway responsiveness to leukotrienes C4 and D4 and to methacholine in patients with asthma and normal controls. N Engl J Med 315:480–484
Aiken JW (1984) Prostaglandins. J Cardiovasc Pharmacol 6: S413-S420
Alpan G, Eyal F, Vinograd J, Udassin R, Amir G, Mogle P, Glick B (1985) Localized intestinal perforations after enteral administration of indomethacin in premature infants. J Pediatr 106: 277–281
Arcilla RA, Thilenius OG, Ranniger K (1969) Congestive heart failure from suspected ductal closure in utero. J Pediatr 75:74–78
Bergström S, Sjövall J (1960) The isolation of prostaglandin E from sheep prostate glands. Acta Chem Scand 14:1701–1705
Bergström S, Ryhage R, Samuelsson B, Sjövall J (1963) Prosta-glandins and related factors: the structures of prostaglandin E1, F1α, and F1β. J Biol Chem 238:3555–3564
Bergström S, Danielsson H, Samuelsson B (1964) The enzymatic formation of prostaglandin E2 from arachidonic acid. Prostaglandins and related factors 32. Biochem Biophys Acta 90:207–210
Blair IA, Barrow SE, Waddell KA, Lewis PJ, Dollery CT (1982) Prostacyclin is not a circulating hormone in man. Prostaglandins 23:579–590
Brash AR, Jackson EK, Saggese CA, Lawson JA, Oates JA, FitzGerald GA (1983) Metabolic disposition of prostacyclin in humans. J Pharmacol Exp Ther 226:78–87
Catella F, Nowak J, FitzGerald GA (1986) Measurement of renal and non-renal eicosanoid synthesis. Am J Med 81 [Suppl 2B]: 23–29
Catella F, Healy D, Lawson J, FitzGerald GA (1986) 11-dehydrothromboxane B2: a quantitative index of thromboxane A2 formation in the human circulation. Proc Natl Acad Sci USA 83:5861–5865
Clive DM, Stoff JS (1984) Renal syndromes associated with nonsteroidal antiinflammatory drugs. N Engl J Med 310:563–572
Coceani F, Olley PM (1973) The response of the ductus arteriosus to prostaglandins. Can J Physiol Pharmacol 51:220–225
Coceani F, Bishai I, Dinarello CA, Fitzpatrick FA (1983) Prostaglandin E2 and thromboxane B2 in cerebrospinal fluid of afebrile and febrile cat. Am J Physiol 244:R785-R793
Corazza MS, Davis RF, Merritt TA, Bejar R, Cvetnic W (1984) Prolonged bleeding time in preterm infants receiving indomethacin for patent ductus arteriosus. J Pediatr 105:292–296
Donowitz M (1985) Arachidonic acid metabolites and their role in inflammatory bowel disease. An update requiring addition of a pathway. Gastroenterology 88:580–587
Dorp DA van, Beerthuis RK, Nugteren DH, Vonkeman H (1964) The biosynthesis of prostaglandins. Biochim Biophys Acta 90:204–207
Erlenmaier T, Müller H, Seyberth HW (1979) Combined capillary column gas chromatography-mass spectrometric method for the quantitative analysis of urinary prostaglandins. J Chromatogr 163:289–293
Euler US von (1935) Über die spezifische blutdrucksenkende Substanz des menschlichen Prostata- und Samenblasensekretes. Klin Wochenschr 33:1182–1183
Fischer S, Weber PC (1983) Thromboxane A3 (TXA3) is formed in human platelets after dietary eicosapentaenoic acid (C20: 5ω3). Biochem Biophys Res Commun 116:1091–1099
Fischer S, Weber PC (1984) Prostaglandin I3 is formed in vivo in man after dietary eicosapentaenoic acid. Nature 307:165–168
FitzGerald DJ, Roy L, Catella F, FitzGerald GA (1986) Platelet activation in unstable coronary disease. N Engl J Med 315:983–989
FitzGerald GA, Smith B, Pedersen AK, Brash AR (1984) Increased prostacyclin biosynthesis in patients with severe atherosclerosis and platelet activation. N Engl J Med 310:1065–1068
Fleisch JH, Rinkema LE, Haisch KD, Swanson-Bean D, Goodson T, Ho PPK, Marshall WS (1985) LY171883, 1-(2-hydroxy-3-propyl-4-(4-1H-tetrazol-5-yl) butoxy)phenyl)ethanone, an orally active leukotriene D4 antagonist. J Pharmacol Exp Ther 233: 148–157
Flower RJ (1986) Inflammation. The mediators of steroid action. Nature 320:20
Flower RJ, Vane JR (1974) Commentary. Inhibition of prostaglandin biosynthesis. Biochem Pharmacol 23:1439–1450
Foegh ML, Alijani MR, Helfrich GB, Khirabadi BS, Lim K, Ramwell PW (1986) Lipid mediators in organ transplantation. Transplant Proc 18[Suppl 4]:20–24
Fredholm BB, Hedqvist P (1973) Role of pre- and postjunctional inhibition by prostaglandin E2 of lipolysis induced by sympathetic nerve stimulation in dog subcutaneous adipose tissue in situ. Br J Pharmacol 47:711–718
Freed MD, Heymann MA, Lewis AB, Roehl SL, Chen Kensey R (1981) Prostaglandin E1 in infants with ductus arteriosus-dependent congenital heart disease. Circulation 64:899–905
Friedman WF, Printz MP, Kirkpatrick SE, Hoskins EJ (1983) The vasoactivity of the fetal lamb ductus arteriosus studied in utero. Pediatr Res 17:331–337
Frölich JC, Wilson FW, Sweetman BJ, Smigel M, Nies AS, Carr K, Watson JT, Oates JA (1975) Urinary prostaglandins: identification and origin. J Clin Invest 55:763–770
Garin EH, Sausville PJ, Richard GA (1983) Serum inhibitor of phytohemagglutinin-induced lymphocyte proliferation in Bartter syndrome. J Pediatr 102:569–572
Gersony WM, Peckham GJ, Ellison RC, Miettinen OS, Nadas AS (1983) Effects of indomethacin in premature infants with patent ductus arteriosus: results of a national collaborative study. J Pediatr 102:895–906
Goldblatt WA (1933) A depressor substance in seminal fluid. J Soc Chem Ind (London) 52:1056–1057
Goodman RP, Killam AP, Brash AR, Branch RA (1982) Prostacyclin production during pregnancy: comparison of production during normal pregnancy and pregnancy complicated by hypertension. Am J Obstet Gynecol 142:817–822
Goodwin JS, Ceuppens J (1983) Regulation of the immune response by prostaglandins. J Clin Immunol 3:295–315
Granström E, Kindahl H (1978) Radioimmunoassay of prostaglandins and thromboxanes. Adv Prostaglandin Thromboxane Leukotriene Res 5:119–207
Granström E, Samuelsson B (1978) Quantitative measurement of prostaglandins and thromboxanes: general considerations. Adv Prostaglandin Thromboxane Leukotriene Res 5:1–12
Gresele P, Arnout J, Janssens W, Deckmyn H, Lemmens J, Vermylen J (1984) BM 13.777, a selective blocker of platelet and vessel wall thromboxane receptors, is active in man. Lancet I: 991–993
Hagmann W, Denzlinger C, Rapp S, Weckbecker G, Keppler D (1986) Identification of the major endogenous leukotriene metabolite in the bile of rats as N-acetyl leukotriene E4. Prostaglandins 31:239–251
Halushka PV, Mais DE, Saussy DL Jr (1987) Platelet and vascular smooth muscle thromboxane A2/prostaglandin H2 receptors. Fed Proc 46:149–153
Hamberg M, Svensson J, Samuelsson B (1975) Thromboxanes: a new group of biologically active compounds derived from prostaglandin endoperoxides. Proc Natl Acad Sci USA 72:2994–2998
Hammerström S (1983) Leukotrienes. Ann Rev Biochem 52: 355–377
Harker LA (1986) Clinical trials evaluating platelet-modifying drugs in patients with atherosclerotic cardiovascular disease and trombosis. Circulation 73:206–223
Heymann MA (1984) Control of the pulmonary circulation in the perinatal period. J Dev Physiol 6:281–290
Heymann MA, Rudolph AM (1976) Effects of acetylsalicylic acid on the ductus arteriosus and circulation in fetal lambs in utero. Circ Res 38:418–422
Itskovitz J, Abramovici H, Brandes JM (1980) Oligohydramnion, meconium and perinatal death concurrent with indomethacin treatment in human pregnancy. J Reprod Med 24:137–140
Jones VA, McLaughlan P, Shorthouse M, Workman E, Hunter JO (1982) Food intolerance: a major factor in the pathogenesis of irritable bowel syndrome. Lancet II:1115–1117
Kets H van, Thiery M, Derom R, Egmond H van, Baele G (1979) Perinatal hazards of chronic antenatal tocolysis with indomethacin. Prostaglandins 18:893–907
Knapp HR, Reilly IAG, Alessandrini P, FitzGerald GA (1986) In vivo indexes of platelet and vascular function during fish-oil administration in patients with atherosclerosis. N Engl J Med 314:937–942
Körner CF, Hausmann G, Gemsa D, Resch K (1984) Rate of prostaglandin synthesis is not controlled by phospholipase A activity but by reincorporation of released fatty acids into phospholipids. Agents Actions 15:28–30
Kühl G, Wille L, Bolkenius M, Seyberth HW (1985) Intestinal perforation associated with indomethacin treatment in premature infants. Eur J Pediatr 413:213–216
Kühl PG, Bolds JM, Loyd JE, Snapper JR, FitzGerald GA (1987) Thromboxane vascular and airway changes in the presence of increased thromboxane biosynthesis in sheep endotoxemia. In: Samuelsson B, Paoletti R, Ramwell P (eds) Advances in prostaglandin, thromboxane and leukotriene research. Raven Press, New York (in press)
Kurzrok R, Lieb C (1930) Biochemical studies of human semen. II. The action of semen on the human uterus. Proc Soc Exp Biol Med 28:268–272
Lapetina EG (1982) Regulation of arachidonic acid production: role of phospholipases C and A2. Trends Pharmacol Sci 3:115–118
Lawson JA, Brash AR, Doran J, FitzGerald GA (1985) Measurement of urinary 2,3-dinor-thromboxane B2 and thromboxane B2 using bonded-phase phenylboronic acid columns and capillary gas chromatography-negative ion chemical ionization mass spectrometry. Anal Biochem 150:463–470
Lawson JA, Patrono C, Ciabattoni G, FitzGerald GA (1986) Long-lived enzymatic metabolites of thromboxane B2 in the human circulation. Anal Biochem 155:198–205
Lee TH, Hoover RL, Williams JD, Sperling RI, Ravalese III J, Spur BW, Robinson DR, Corey EJ, Lewis RA, Austen KF (1985) Effect of dietary enrichment with eicosapentaenoic and docosahexaenoic acids on in vitro neutrophil and monocyte leukotriene generation and neutrophil function. N Engl J Med 312:1217–1224
Leffler CW, Hessler JR (1981) Perinatal pulmonary prostaglandin production. Am J Physiol 241:H756-H759
Leonhardt A, Isken V, Kühl PG, Seyberth HW (1987) Prolonged indomethacin treatment in preterm infants with symptomatic patent ductus arteriosus: efficacy, drug level monitoring, and patient selection. Eur J Pediatr 146:140–144
Levin DL, Fixler DE, Morriss FC, Tyson J (1987) Morphologic analysis of the pulmonary vascular bed in infants exposed in utero to prostaglandin synthetase inhibitors. J Pediatr 92:478–483
Lewis RA, Austen KF (1984) The biologically active leukotrienes, biosynthesis, metabolism, receptors, functions and pharmacology. J Clin Invest 73:889–894
Lewis AB, Freed MB, Heymann MA, Roehl SL, Chen Kensey R (1981) Side effects of therapy with prostaglandin E1 in infants with critical congenital disease. Circulation 64:893–898
Liston TE, Roberts L (1985) Metabolic fate of radiolabeled prostaglandin D2 in a normal human male volunteer. J Biol Chem 260:13172–13180
Maher P, Lane B, Ballard R, Piecuch R, Clyman RI (1985) Does indomethacin cause extension of intracranial hemorrhages: A preliminary study. Pediatrics 75:497–500
Majerus PW (1976) Why aspirin? Circulation 54:357–359
Massicot JG, Soberman RJ, Ackerman NR, Heavey D, Roberts II LJ, Austen KF (1986) Workshop: potential therapeutic uses of inhibitors of leukotriene generation and function. Prostaglandins 32:481–494
Miller OV, Gorman RR (1979) Evidence for distinct prostaglandin I2 and D2 receptors in human platelets. J Pharmacol Exp Ther 210:134–140
Minford AMB, Barr DGD (1980) Prostaglandin synthetase inhibitor in an infant with congenital chloride diarrhoea. Arch Dis Child 55:70–72
Moncada S, Vane JR (1979) Arachidonic acid metabolites and the interactions between platelets and blood-vessel walls. N Engl J Med 300:1142–1147
Moncada S, Gryglewski R, Bunting S, Vane JR (1976) An enzyme isolated from arteries transforms prostaglandin endoperoxides to an unstable substance that inhibits platelet aggregation. Nature 263:663–665
Müller H, Mrongovius R, Seyberth HW (1981) Improved sample preparation for the quantitative mass spectrometric determination of prostaglandins in biological samples. J Chromatogr 226: 450–454
Needleman P, Turk J, Jakschik BA, Morrison AR, Lefkowith JB (1986) Arachidonic acid metabolism. Ann Rev Biochem 55:69–102
O'Brien JR, Oxon DM, Path FC (1968) Effects of salicylates on human platelets. Lancet I:779–783
Ogletree ML (1987) Overview of physiological and pathophysiological effects of thromboxane A2. Fed Proc 46:133–138
Ogletree ML, Harris DN, Greenberg R, Haslanger MF, Nakane M (1985) Pharmacological actions of SQ 29,548, a novel selective thromboxane antagonist. J Pharmacol Exp Ther 234:435–441
Patrono C, Pierucci A (1986) Renal effects of nonsteroidal antiinflammatory drugs in chronic glomerular disease. Am J Med 81 [Suppl 2B]:71–83
Patrono C, Ciabattoni G, Pugliese F, Pierucci A, Blair IA, FitzGerald GA (1986) Estimated rate of thromboxane secretion into the circulation of normal humans. J Clin Invest 77:590–594
Peskar BM (1977) On the synthesis of prostaglandins by human gastric mucosa and its modification by drugs. Biochim Biophys Acta 487:307–314
Philips JB III, Lyrene RK (1984) Prostaglandins, related compounds, and the perinatal pulmonary circulation. Clin Perinatol 11:565–579
Powell VS (1980) Rapid extraction of oxygenated metabolites of arachidonic acid from biological samples using octadecylsilyl silica. Prostaglandins 20:947–957
Rachmilewitz D (1980) Prostaglandins and diarrhea. Dig Dis Sci 25:897–899
Rasmussen H (1986) The calcium messenger system (two parts). N Engl J Med 314:1094–1101, 1164–1170
Reilly IAG, Doran JB, Smith B, FitzGerald GA (1986) Increased thromboxane biosynthesis in a human preparation of platelet activation: biochemical and functional consequences of selective inhibition of thromboxane synthase. Circulation 73: 1300–1309
Robert A (1974) Effects of prostaglandins on the stomach and the intestine. Prostaglandins 6:523–532
Roberts LJ II, Sweetman BJ, Lewis RA, Austen KF, Oates JA (1980) Increased production of prostaglandin D2 in patients with systemic mastocytosis. N Engl J Med 303:1400–1404
Roberts LJ II, Sweetman BJ, Oates JA (1981) Metabolism of thromboxane B2 in man. J Biol Chem 256:8384–8393
Roth GJ, Stanford N, Majerus PW (1975) Acetylation of prostaglandin synthase by aspirin. Proc Natl Acad Sci USA 72:3073–3076
Roy L, Knapp HR, Robertson RM, FitzGerald GA (1985) Endogenous biosynthesis of prostacyclin during cardiac catheterization and angiography in man. Circulation 71:434–440
Rumack CM, Guggenheim MA, Rumack BH, Peterson RG, Johnson ML, Braithwaite WR (1981) Neonatal intracranial hemorrhage and maternal use of aspirin. Obstet Gynecol 58: 52S-56S
Runkle B, Goldberg RN, Streitfeld MM, Clark MR, Buron E, Setzer ES, Bancalari E (1984) Cardiovascular changes in group B streptococcal sepsis in the piglet: response to indomethacin and relationship to prostacyclin and thromboxane A2. Pediatr Res 18:874–878
Rusk-Madsen J, Bukhave K (1979) Prostaglandins and chronic diarrhoea: clinical aspects. Scand J Gastroenterol 14 [Suppl 53]: 73–78
Samuelsson B, Granström E, Green K, Hamberg M (1971) Metabolism of prostaglandins. Ann NY Acad Sci 180:138–163
Samuelsson B, Granström E, Green K, Hamberg M, Hammarström S (1975) Prostaglandins. Ann Rev Biochem 44:669–695
Schlöndorff D, Ardaillou R (1986) Prostaglandins and other arachidonic acid metabolites in the kidney. Kidney Int 29:108–119
Schreiber MD, Heymann MA, Soifer SJ (1985) Leukotriene inhibition prevents and reverses hypoxic pulmonary vasoconstriction in newborn lambs. Pediatr Res 19:437–441
Schweer H, Kammer J, Kühl PG, Seyberth HW (1986) Determination of peripheral plasma prostanoid concentration: an unreliable index of ‘in vivo’ prostanoid activity. Eur J Clin Pharmacol 31:303–305
Schweer H, Seyberth HW, Schubert R (1986) Determination of prostaglandin E2, prostaglandin F2α and 6-oxoprostaglandin F1α in urine by gas chromatography/mass spectrometry and gas chromatography/tandem mass spectrometry: a comparison. Biomed Environ Mass Spectrom 13:611–619
Schweer H, Meese CO, Fürst O, Kühl PG, Seyberth HW (1987) Tandem mass spectrometric determination of 11-dehydrothromboxane B2, an index metabolite of thromboxane B2 in plasma and urine. Anal Biochem 164:156–165
Serafin WE, Oates JA, Hubbard WC (1984) Metabolism of leukotriene B4 in the monkey. Identification of the principal nonvolatile metabolite in the urine. Prostaglandins 27:899–911
Serhan CN, Hamberg M, Samuelsson B, Morris J, Wishka DG (1986) On the stereochemistry and biosynthesis of lipoxin B. Proc Natl Acad Sci USA 83:1983–1987
Seyberth HW (1987) Prostaglandins (arachidonate cascade). In: Holliday MA, Barratt TM, Vernier R (eds) Pediatric nephrology, 2nd edn. Williams & Wilkins, Baltimore, pp 232–241
Seyberth HW, Oelz O, Kennedy T, Sweetman BJ, Danon A, Frölich JC, Heimberg M, Oates JA (1975) Increased arachidonate in lipids following its administration to man: effects on prostaglandin biosynthesis. Clin Pharm Ther 18:521–529
Seyberth HW, Segre GV, Morgan JL, Sweetman BJ, Potts JT, Oates JA (1975) Prostaglandins as mediator of hypercalcemia associated with certain types of cancer. N Engl J Med 293:1278–1283
Seyberth HW, Müller H, Ulmer HE, Wille L (1984) Urinary excretion rates of 6-keto-PGF1α in preterm infants recovering from respiratory distress with and without patent ductus arteriosus. Pediatr Res 18:520–524
Seyberth HW, Rascher W, Schweer H, Kühl PG, Mehls O, Schärer K (1985) Congenital hypokalemia with hypercalciuria in preterm infants: a hyperprostaglandinuric tubular syndrome different from Bartter syndrome. J Pediatr 107:694–701
Seyberth HW, Königer SJ, Rascher W, Kühl PG, Schweer H (1987) Role of postaglandins in hereditary tubular disorders: introduction of a hyperprostaglandin E syndrome. Pediatr Nephrol 1:491–497
Sideris EB, Yokochi K, Coceani F, Olley PM (1985) Prostaglandins and fetal cardiac output distribution in the lamb. Am J Physiol 248:H853-H858
Soifer SJ, Loitz RD, Roman C, Heymann MA (1985) Leukotriene end organ antagonists increase pulmonary blood flow in fetal lambs. Am J Physiol 249:H570-H576
Stenmark KR, James SL, Voelkel NF, Toews WH, Reeves JT, Murphy RC (1983) Leukotriene C4 and D4 in neonates with hypoxemia and pulmonary hypertension. N Engl J Med 309:77–80
Stjernschantz J (1984) The leukotrienes. Med Biol 62:215–230
Stork JE, Rahman MA, Dunn MJ (1986) Eicosanoids in experimental and human renal disease. Am J Med 80 [Suppl 1A]:34–45
Stuart MJ, Gross SJ, Elrad H, Graeber JE (1982) Effects of acetylsalicylic-acid ingestion on maternal and neonatal hemostasis. N Engl J Med 307:909–912
Ueda K, Saito A, Nakamo H, Aoshima M, Yokota M, Muraoka R, Iwaya T (1980) Cortical hyperostosis following long-term administration of prostaglandin E1 in infants with cyanotic heart disease. J Pediatr 97:834–836
Vane JR (1971) Inhibition of prostaglandin synthesis as a mechanism of action of aspirin-like drugs. Nature 231:232–235
Wallen LD, Murai DT, Clyman RI, Lee CH, Mauray FE, Kittermann JA (1986) Regulation of breathing movements in fetal sheep by prostaglandin E2. J Appl Physiol 60:526–531
Wallenburg HCS, Makovitz JW, Dekker GA, Rotmans P (1986) Low-dose aspirin prevents pregnancy-induced hypertension and pre-eclampsia in angiotensin-sensitive primigravidae. Lancet I:1–3
Weiner BH, Ockene IS, Levine PH, Cuénoud HF, Fisher M, Johnson BF, Daoud AS, Jarmolych J, Hosmer D, Johnson MH, Natale A, Vaudreuil C, Hoogasian JJ (1986) Inhibition of atherosclerosis by cod-liver oil in a hyperlipidemic swine model. N Engl J Med 315:841–846
Wennmalm A (1978) Effects of nicotine on cardiac prostaglandin and platelet thromboxane synthesis. Br J Pharmacol 64:559–563
Zuckerman H, Reiss U, Rubinstein I (1974) Inhibition of human premature labor by indomethacin. Obstet Gynecol 44:787–792
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Seyberth, H.W., Kühl, P.G. The role of eicosanoids in paediatrics. Eur J Pediatr 147, 341–349 (1988). https://doi.org/10.1007/BF00496408
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00496408